Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis
- 22 December 2004
- journal article
- research article
- Published by Elsevier in Acta Tropica
- Vol. 93 (2) , 161-167
- https://doi.org/10.1016/j.actatropica.2004.10.007
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Leishmaniasis– current chemotherapy and recent advances in the search for novel drugsTrends in Parasitology, 2003
- Current treatment approaches to leishmaniasisCurrent Opinion in Infectious Diseases, 2003
- A Randomized, Double‐Blind Study of the Efficacy of a 10‐ or 20‐Day Course of Sodium Stibogluconate for Treatment of Cutaneous Leishmaniasis in United States Military PersonnelClinical Infectious Diseases, 2002
- Combined Interleukin‐12 and Topical Chemotherapy for Established Leishmaniasis Drastically Reduces Tissue Parasitism and Relapses in Susceptible MiceThe Journal of Infectious Diseases, 2001
- Comparison of Cutaneous Leishmaniasis Due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: Clinical Findings and Diagnostic ApproachClinical Infectious Diseases, 2001
- Interleukin‐12 Regulates the Response to Chemotherapy in Experimental Visceral LeishmaniasisThe Journal of Infectious Diseases, 2000
- Effect of glucantime on field and patient isolates of New World Leishmania ?: use of growth parameters of promastigotes to assess antimony susceptibilityZeitschrift Fur Parasitenkunde-Parasitology Research, 1998
- LeishmaniasisJournal of the American Academy of Dermatology, 1996
- The sensitivity of Leishmania species to aminosidineJournal of Antimicrobial Chemotherapy, 1995
- Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animalsAntimicrobial Agents and Chemotherapy, 1984